Skip to content

UTAH MEDICAL PRODUCTS INC

UTMD

CIK 0000706698

← back to feed
Revenue (TTM)
$38.2M
−7.8% YoY Q1 May 2026
Net Income (TTM)
$11.32M
−2.5% YoY Q1 May 2026
EPS Diluted (TTM)
$3.50
−2.4% YoY Q1 May 2026
Gross Margin
57.6%
Q1 May 2026
Operating Margin
30.2%
Q1 May 2026
Net Margin
29.6%
Q1 May 2026
Free Cash Flow (TTM)
$19.39M
Q1 May 2026
Cash
$87.41M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
3.18M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings